CleverHealth Network’s newest member Clinipower Finland Oy helps health technology innovators enter EU markets by offering regulatory expertise in the health sector. Founded in 2015, Clinipower supports companies in developing digital healthcare innovations, particularly in navigating EU requirements, approvals and fitting new solutions into real-world clinical environments and existing systems.
Clinipower’s founder and CEO Maija Laukkanen has worked in health technology for many years, including about 20 years at GE Healthcare, and is especially interested in how data can be used in clinical work. Senior Specialist Pekka Kola has a background in intensive care information systems and measuring healthcare quality. Both are familiar with HUS and CleverHealth Network, and Clinipower a has contributed to several CHN projects.
Clinipower’s core business is consulting, complemented by participation in EU projects. Laukkanen notes that the company does not do product development; instead, it supports product development organisations with topics such as EU requirements for medical devices and digital health solutions, and interpreting and applying regulations in the different life cycle stages of software.
Why CHN and what Clinipower brings to the network
In the CHN community, Clinipower values networking and learning: development needs come from a genuine environment, and the company wants to contribute to projects where solutions are tested and validated in day-to-day clinical work. For the network, Clinipower brings their versatile expertise in quality control and regulation processes in the digitalisation of healthcare (e.g. CE, MDR, AI Act and requirements of EHDS), commercialisation and lessons learned from EU projects, which it aims to help roll out especially for SMEs. The aim is to streamline the implementation of new solutions both in Finland and around the world.
Maija Laukkanen concludes that the goal for health technology innovations is to deliver real benefits in healthcare, not just novelty. The impact and cost effectiveness of digitalisation is constantly being assessed, which supports both decision-making and commercialisation of solutions.
Looking ahead, the ambition is to create, together with CHN partners, internationally meaningful, system-level progress and concrete solutions to the markets. When strong expertise in the digitalisation of the health care and good operational and product management, early inclusion of regulation as well as implementation and impact thinking go hand in hand, Finnish organisations are better positioned to build concrete solutions that have a good fit with the EU’s unifying digital markets for health care.
